Antinuclear autoantibodies and pregnancy outcome in women with unexplained recurrent miscarriage

American Journal of Reproductive Immunology

Volumn 76, Issue 5, 2016, Pages 396-399

  Ticconi, Carlo ^a   Pietropolli, Adalgisa ^a   Borelli, Barbara ^a   Bruno, Valentina ^a   Piccione, Emilio ^a   Bernardini, Sergio ^a   Di Simone, Nicoletta ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

antinuclear autoantibodies; autoimmunity; recurrent miscarriage

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CESAREAN SECTION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOFLUORESCENCE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; VAGINAL DELIVERY;

EID: 84990190257     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12560     Document Type: Article

References (11)

1. Jeve YB, Davies W. Evidence-based management of recurrent miscarriage. J Hum Reprod Sci. 2014;7:159–169.
2. Racicot K, Kwon J-Y, Aldo P, Silasi M, Mor G. Understanding the complexity of the immune system during pregnancy. Am J Reprod Immunol. 2014;72:107–116.
3. Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A. Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol. 2014;72:129–140.
4. Giannouli E, Chatzidimitriou D, Gerou S, Gavrilaki E, Settas L, Diza E. Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods. Clin Rheumatol. 2013;32:1541–1546.
5. Faria AC, Barcellos KS, Andrade LE. Longitudinal fluctuations of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol. 2005;32:1267–1272.
6. Ticconi C, Rotondi F, Veglia M, et al. Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol. 2010;64:304–392.
7. Zhu Q, Wu L, Xu B, et al. A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment. Reprod Biol Endocrinol. 2013;11:98.
8. Kaider BD, Coulam CB, Roussev RG. Murine embryos as a direct target for some human autoanibodies in vitro. Hum Reprod. 1999;14:2556–2561.
9. Cavalcante MB, da Silva Costa F, Araujo EJr, Barini R. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy. J Matern Fetal Neonatal Med. 2014;28:1092–1096.
10. Sakthiswary R, Rajalingam S, Norazman MR, Hussien H. Antinuclear antibodies predict a higher number of pregnancy loss in unexplained recurrent pregnancy loss. Clin Ter. 2015;166:e98–e101.
11. Veglia M, D'Ippolito S, Marana R, et al. Human IgG antinuclear antibodies induce pregnancy loss in mice by increasing immune complex deposition in placental tissue: in vivo study. Am J Reprod Immunol. 2015;74:542–552.